Protek Implementation Center

The PROTEK Implementation Center is one of the largest distributors of pharmaceuticals and beauty and health products in Russia, a key company of the PROTEK Group.

History

2024: Co-owner of the pharmaceutical distributor Godovalov will pay 500 million rubles to the Protek group in the case of debt collection

The Arbitration Court Moscow of the city on May 28, 2024 ruled to recover 500 million from the entrepreneur Nikolai Shavrin rubles in favor of the pharmaceutical distributor Protek. This amount is part of the debt formed in connection with the bankruptcy of Godovalov LLC, co-owned by Shavrin.

According to the court, the Protek Implementation Center company sought to issue a writ of execution to recover funds from Godovalov LLC, as well as its founders, Andrei Godovalov and Nikolai Shavrin. The court partially satisfied the plaintiff's claims, deciding to recover from Shavrin as a guarantor 500 million rubles of principal debt and 200 thousand rubles of state duty costs.

𝓲

Unsplash

So far, a decision has been made to recover 500 million rubles. from Shavrin - guarantor of Godovalov LLC, - confirmed Dmitry Pogrebinsky, general director of Protek CV.

He also added that the prospects for receiving funds for our side are still ambiguous, since the bankruptcy procedure of an individual entrepreneur has begun against Nikolai Shavrin.

Earlier, Pogrebinsky reported that in total, the Protek group lost a little more than 1 billion rubles due to the bankruptcy of Godovalov. At the same time, the distributor did not tighten the requirements for pharmacy chains, but only followed the standard rules for the industry.

The Godovalov company was one of the largest players in the regional pharmaceutical market, working in 37 constituent entities of the Russian Federation. In March 2024, the Arbitration Court of the Perm Territory declared bankrupt the co-owners of the enterprise - Andrei Godovalov and Nikolai Shavrin, introducing a procedure for the sale of property against them.

According to Pogrebinsky, the risks of further bankruptcies of large pharmacy chains remain on the market, in connection with which Protek is cautiously approaching shipments of products to partners with dubious solvency, trying to avoid new losses.^[1]

2023

Construction in the Moscow region of a warehouse for storing drugs for 1.3 billion rubles

Protek built a new warehouse for storing drugs in the Moscow region for 1.3 billion rubles. This was announced on August 29, 2023 by the press service of the Ministry of Housing Policy of the Moscow Region. This department issued permission to put the facility into operation. Read more here.

Entering a leadership position in the supply of drugs in Russia

The Protek group of companies, the main owner of which is Russian businessman Vadim Yakunin, in the first quarter of 2023 again became the leading supplier of drugs in Russia. This is stated in the DSM Group study, the results of which were released in early May 2023. Read more here.

Purchase of the chemical-pharmaceutical company "Bion"

Protek Group of Companies bought from the main shareholder of VSMPO-Avisma Corporation Mikhail Shelkov the assets of the chemical-pharmaceutical company Bion. This became known in early February 2023. Read more here.

2022: General Director of Atlas Investments withdrew from the capital of the Zdravsiti online pharmacy

In December 2022, it became known about the change of co-owners of the Zdravsiti online pharmacy. According to the SPARK-Interfax system, Andrei Perfiliev, general director of Atlas Investments, transferred to the Protek group (one of the largest pharmaceutical distributors in the Russian Federation). We are talking about 3%. Read more here.

2020: Purchase of the Atlas clinic for 110 million rubles

At the end of June 2020, it became known about the sale of the Atlas clinic to the Protek group, which includes the Rigla, Be Healthy and Zhivika pharmacy chains. The transaction cost amounted to 110 million rubles. Read more here.

2019: Agreement with Sechenov University to establish a joint venture for the development of telemedicine

On November 26, 2019, Sechenov Medical University informed TAdviser about the signing of an agreement on the creation of a joint venture on the basis of the university with the Protek Implementation Center. The document was signed by the rector of Sechenov University, academician of the Russian Academy of Sciences Pyotr Glybochko and general director of the PROTEK CV Dmitry Pogrebinsky. Read more here.

2010

CV PROTEK is a national-level distributor that operates in all 83 constituent entities of the Russian Federation. AS of November 2010, the regional network has 41 branches, 29 regional trade offices. The range of PROTEK CV - more than 14,000 items of medicines, parapharmaceuticals and medical products.

The customer base of the company covers all segments of the pharmaceutical market: single pharmacies, pharmacy chains, medical and preventive institutions, wholesale companies, as well as regions within the framework of the ONLS program. In general, the client base has more than 18,000 clients (44,000 pharmacies and medical and preventive institutions).

The total area of ​ ​ the storage facilities of the PROTEK CV is more than 160,000 square meters. m The company's central logistics complex, the Transservice customs and warehouse terminal, is located in Pushkino, 14 kilometers from Moscow along the Yaroslavl highway. The total area of ​ ​ the Trans-Service CCR is 56,000 sq.m. (more than 50,000 pallet seats).

CV PROTEK has one of the most powerful automated complex in the country for collecting retail customer orders. It can process up to 370 thousand items per day (according to the company).

Notes